Large drugmakers with the lowest PE ratio
Share price divided by earnings per share over the last twelve months. As of .
- Ranked
- 41
- of 411 large drugmakers we cover
- Median
- 19.1×
- Lowest
- 2.5×
- CRMD
- Range
- 2.5× to 192×
median 19.1×
2.5×192×
Not ranked: 289 with a loss over the last year, 20 with a quarter missing, 11 with not a meaningful number. 50 companies whose data behind this number has a caveat are left out until it is checked.
A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.
PE for other groups
Other rankings of large drugmakers
- Large drugmakers cheapest against their own PE history
- Large drugmakers with the lowest price to sales ratio
- Large drugmakers with the lowest EV/EBIT
- Large drugmakers with the highest free cash flow yield
- Large drugmakers with the fastest revenue growth
- Large drugmakers with the fastest earnings growth
- Large drugmakers with the highest profit margins